20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4031 | S1p receptor agonist 1 | S1p-receptor-agonist-1 | S1P Receptor , LPL Receptor |
S1p receptor agonist 1 (S1p-receptor-agonist-1) is an S1P receptor agonist. | |||
T21500 | Sphingosine-1-phosphate | S1P | Endogenous Metabolite , S1P Receptor , LPL Receptor |
Sphingosine-1-phosphate (S1P) is an agonist for S1P1-5 receptors and a ligand for GPR3, GPR6, GPR12.Sphingosine-1-phosphate is an intracellular second messenger that mobilises Ca2+ as an extracellular ligand for G-protei... | |||
T62517 | S1p receptor agonist 2 | ||
S1p receptor agonist 2 (compound 1) is an agonist of the S1P5 receptor with a higher selectivity than S1P1 and/or S1P3 receptors.S1p receptor agonist 2 can be used in the endogenous SIP signaling system and in the mitiga... | |||
T6923 | Ozanimod | RPC-1063 | S1P Receptor , LPL Receptor |
Ozanimod (RPC-1063) (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclero... | |||
T8461 | SKI V | Apoptosis , PI3K , S1P Receptor | |
SKI V is a potent and noncompetitive non-lipid sphingosine kinase (SPHK; SK) inhibitor (GST-hSK,IC50 : 2 μM), and is a PI3K inhibitor(hPI3k,IC50 : 6 μM), induces apoptosis and has antitumor activity | |||
T83910 | S1PL-IN-31 | Sphingosine-1-Phosphate Lyase Inhibitor 31,S1PL Inhibitor 31,S1P Lyase Inhibitor 31 | |
S1PL-IN-31 is a dual-function chemical compound acting as an inhibitor of sphingosine-1-phosphate (S1P) lyase with an IC50 value of 210 nM and as an antagonist of the Smoothened (Smo) receptor with an IC50 of 440 nM. Dem... | |||
T6403 | Siponimod | BAF-312 | S1P Receptor , LPL Receptor |
BAF312 (Siponimod (BAF-312)), a next-generation S1P receptor modulator, is specific for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, respectively. The specificity of BAF312 for S1P1 and S1P5 receptors exhibi... | |||
TQ0138 | K145 hydrochloride | Apoptosis , S1P Receptor | |
K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 µM and Ki of 6.4 µM. K145 hydrochloride can induce apoptosis and has strong antitumor activity. | |||
T6085 | PF-543 | Sphingosine Kinase 1 Inhibitor II,PF 543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM. | |||
T8840 | PF-543 hydrochloride | PF-543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 hydrochloride (PF-543) inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform. | |||
T28643 | S1P1-IN-Ex26 | ||
S1P1-IN-Ex26 is a potent, selective antagonist of S1P1 receptor. | |||
T12821 | S1PR1 modulator 1 | LPL Receptor | |
S1PR1 modulator 1 is a selective inhibitor of S1PR1 with a pIC50 of 7.6. | |||
T63378 | S1PR1 agonist 1 | ||
S1PR1 agonist 1 is a potent agonist of S1PR1. S1PR1 agonist 1 has potential in autoimmune diseases. | |||
T62886 | S1PR1 agonist 2 | ||
S1PR1 agonist 2 is a potent agonist of S1PR1. S1PR1 agonist 2 has potential for studies of autoimmune diseases. | |||
T62732 | S1P1 agonist 5 | ||
S1P1 agonist 5 is a selective, orally active S1P1 agonist. S1P1 agonist 5 inhibits the drainage of lymphocytes from lymphoid tissue into peripheral blood. S1P1 agonist 5 has potential for studies in multiple sclerosis (M... | |||
T79817 | S1P1 agonist 6 hemicalcium | LPL Receptor | |
Compound I (S1P1 agonist 6 hemicalcium) is an S1P1 agonist that diminishes autoimmune activity by inhibiting lymphocyte trafficking, and serves as an immunosuppressive agent in researching a range of autoimmune diseases ... | |||
T39798 | S1P2 antagonist 1 | ||
S1P2 antagonist 1 is an orally bioavailable S1P2 antagonist against fibrotic diseases. | |||
T72294 | S1P5 receptor agonist-1 | ||
S1P5 Receptor Agonist-1 (example 6) is a highly potent and selective agonist for the S1P5 receptor, exhibiting an EC50 value of 20 nM. | |||
T79816 | S1P1 agonist 6 | LPL Receptor | |
Compound I (S1P1 agonist 6) is an S1P1 agonist that mitigates autoimmune activity by inhibiting lymphocyte trafficking and has potential as an immunosuppressive agent in autoimmune disease research [1]. | |||
T16833 | S1P1 Agonist III | Others | |
S1P1 Agonist III is an effective and orally active S1P1 agonist (EC50: 18 nM). |